AtriCure (ATRC) Non-Current Assets (2010 - 2026)
AtriCure's (ATRC) quarterly Non-Current Assets came in at $331.1 million in Q2 2026, down 1.92% year-over-year from $337.6 million in Q2 2025, and little changed quarter-over-quarter from $330.3 million in Q1 2026.
Analysis
AtriCure (ATRC) Non-Current Assets (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Non-Current Assets for 17 consecutive years, with $331.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 1.92% year-over-year to $331.1 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 2.76% decrease from a year earlier, with the FY2025 full-year figure at $331.7 million, down 2.88% from the prior year.
- Non-Current Assets was $331.1 million for Q2 2026 at AtriCure, roughly flat from $330.3 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $385.4 million in Q1 2022 and troughed at $330.3 million in Q1 2026.
- A 5-year average of $349.2 million and a median of $345.3 million in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets declined 18.04% in 2022 and advanced 0.47% in 2024, its largest moves.
- Over 5 years, Non-Current Assets stood at $370.2 million in 2022, then declined by 6.09% to $347.7 million in 2023, then fell by 1.78% to $341.5 million in 2024, then fell by 2.88% to $331.7 million in 2025, then slipped by 0.17% to $331.1 million in 2026.
- The last three Non-Current Assets figures came in at $331.1 million (Q2 2026), $330.3 million (Q1 2026), and $331.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 8.29 Bn |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn | 331.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 331.11 Mn |
| Mar 31, 2026 | 330.30 Mn |
| Dec 31, 2025 | 331.66 Mn |
| Sep 30, 2025 | 334.33 Mn |
| Jun 30, 2025 | 337.59 Mn |
| Mar 31, 2025 | 340.15 Mn |
| Dec 31, 2024 | 341.50 Mn |
| Sep 30, 2024 | 345.78 Mn |
| Jun 30, 2024 | 344.42 Mn |
| Mar 31, 2024 | 346.40 Mn |
| Dec 31, 2023 | 347.69 Mn |
| Sep 30, 2023 | 347.55 Mn |
| Jun 30, 2023 | 356.20 Mn |
| Mar 31, 2023 | 344.78 Mn |
| Dec 31, 2022 | 370.23 Mn |
| Sep 30, 2022 | 369.63 Mn |
| Jun 30, 2022 | 381.22 Mn |
| Mar 31, 2022 | 385.38 Mn |
| Dec 31, 2021 | 419.24 Mn |
| Sep 30, 2021 | 417.26 Mn |